Janssen R And D Drug Patent Portfolio
Janssen R And D owns 1 orange book drug protected by 8 US patents Given below is the list of Janssen R And D's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7037917 | HIV replication inhibiting pyrimidines | 13 Jun, 2021 | Expired |
| US7037917 | HIV replication inhibiting pyrimidines | 13 Dec, 2020 | Expired |
| US6878717 | HIV replication inhibiting pyrimidines | 05 May, 2020 | Expired |
| US8003789 | HIV replication inhibiting pyrimidines | 01 May, 2020 | Expired |
| US6878717 | HIV replication inhibiting pyrimidines | 05 Nov, 2019 | Expired |
| US8003789 | HIV replication inhibiting pyrimidines | 01 Nov, 2019 | Expired |
| US7887845 | Antiviral compositions | 25 Sep, 2019 | Expired |
| US7887845 | Antiviral compositions | 25 Mar, 2019 | Expired |
Latest Legal Activities on Janssen R And D's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Janssen R And D.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 25 Sep, 2023 | US8003789 |
|
Maintenance Fee Reminder Mailed
Critical
| 10 Apr, 2023 | US8003789 |
| 11.5 yr surcharge- late pmt w/in 6 mo, Large Entity | 16 Nov, 2022 | US7887845 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 16 Nov, 2022 | US7887845 |
|
Maintenance Fee Reminder Mailed
Critical
| 03 Oct, 2022 | US7887845 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 07 Feb, 2019 | US8003789 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 02 Aug, 2018 | US7887845 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 19 Oct, 2017 | US7037917 |
| Post Issue Communication - Certificate of Correction | 26 Aug, 2013 | US7037917 |
|
Recordation of Patent Grant Mailed
Critical
| 23 Aug, 2011 | US8003789 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 23 Aug, 2011 | US8003789 |
|
Email Notification
Critical
| 04 Aug, 2011 | US8003789 |
|
Issue Notification Mailed
Critical
| 03 Aug, 2011 | US8003789 |
| Dispatch to FDC | 18 Jul, 2011 | US8003789 |
|
Patent Term Extension Certificate
Critical
| 18 Jul, 2011 | US7037917 |
Janssen R And D's Family Patents
Janssen R And D Drug List
Given below is the complete list of Janssen R And D's drugs and the patents protecting them.
1. Intelence
Intelence is protected by 8 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7037917
(Pediatric)
| HIV replication inhibiting pyrimidines |
13 Jun, 2021
(3 years ago)
| Expired |
| US7037917 | HIV replication inhibiting pyrimidines |
13 Dec, 2020
(3 years ago)
| Expired |
| US6878717
(Pediatric)
| HIV replication inhibiting pyrimidines |
05 May, 2020
(4 years ago)
| Expired |
| US8003789
(Pediatric)
| HIV replication inhibiting pyrimidines |
01 May, 2020
(4 years ago)
| Expired |
| US6878717 | HIV replication inhibiting pyrimidines |
05 Nov, 2019
(4 years ago)
| Expired |
| US8003789 | HIV replication inhibiting pyrimidines |
01 Nov, 2019
(4 years ago)
| Expired |
| US7887845
(Pediatric)
| Antiviral compositions |
25 Sep, 2019
(5 years ago)
| Expired |
| US7887845 | Antiviral compositions |
25 Mar, 2019
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Intelence's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List